Skip to main content
SpringerLink
Log in

TAMIS: Indications and Contraindications

  • Chapter
  • First Online:
Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME)

  • 884 Accesses

Abstract

Transanal minimally invasive surgery (TAMIS) is gaining increasing recognition worldwide as an economical alternative to transanal endoscopic microsurgery (TEM). Like TEM, it offers improved visualization in the confined space of the anus and rectum. However, the TAMIS platform is easier to employ. It can be used for local excision of benign neoplasia of the rectum. In addition, TAMIS can be used for the local excision of very select, early-stage invasive rectal cancer, as well as the excision of other, rare neoplasms including gastrointestinal stromal tumors and carcinoid tumors. In appropriately selected patients, local excision via TAMIS can lead to increased rates of organ preservation, without compromising oncologic outcomes. In this chapter we will review the indications and contraindications to the use of TAMIS for local excision.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24:2200–5.

    Article  Google Scholar 

  2. Buess G, Hutterer F, Theiss J, Böbel M, Isselhard W, Pichlmaier H. A system for a transanal endoscopic rectum operation. Chir Z Alle Geb Oper Medizen. 1984;55:677–80.

    CAS  Google Scholar 

  3. Clancy C, Burke JP, Albert MR, O’connell PR, Winter DC. Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum. 2015;58:254–61.

    Article  Google Scholar 

  4. Albert MR, Atallah SB, Debeche-Adams TC, Izfar S, Larach SW. Transanal minimally invasive surgery (tamis) for local excision of benign neoplasms and early-stage rectal Cancer: efficacy and outcomes in the first 50 patients. Dis Colon Rectum. 2013;56:301–7.

    Article  Google Scholar 

  5. Transanal minimally invasive surgery – SAGES clinical spotlight review.

    Google Scholar 

  6. Parks AG. A technique for excising extensive villous papillomatous change in the lower rectum. Proc R Soc Med. 1968;61:441–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Arezzo A, Arolfo S, Allaix ME, Bullano A, Miegge A, Marola S, Morino M. Transanal endoscopic microsurgery for giant circumferential rectal adenomas. Colorectal Dis. 2016;18:897–902.

    Article  CAS  Google Scholar 

  8. Wachter N, Wörns M-A, Dos Santos DP, Lang H, Huber T, Kneist W. Transanal minimally invasive surgery (TAMIS) approach for large juxta-anal gastrointestinal stromal tumour. J Minimal Access Surg. 2016;12:289–91.

    Article  Google Scholar 

  9. Hussein Q, Artinyan A. Pushing the limits of local excision for rectal cancer: transanal minimally invasive surgery for an upper rectal/rectosigmoid lesion. Ann Surg Oncol. 2014;21:1631.

    Article  Google Scholar 

  10. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, Uchida Y. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum. 1995;38:1286–95.

    Article  CAS  Google Scholar 

  11. Chang H-C, Huang S-C, Chen J-S, et al. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol. 2012;19:2477–84.

    Article  Google Scholar 

  12. Maeda K, Koide Y, Katsuno H. When is local excision appropriate for “early” rectal cancer? Surg Today. 2014;44:2000–14.

    Article  Google Scholar 

  13. Kobayashi H, Mochizuki H, Kato T, et al. Is total mesorectal excision always necessary for T1–T2 lower rectal cancer? Ann Surg Oncol. 2010;17:973–80.

    Article  Google Scholar 

  14. Bach SP, Hill J, Monson JRT, Simson JNL, Lane L, Merrie A, Warren B, Mortensen NJM, Association of Coloproctology of Great Britain and Ireland Transanal Endoscopic Microsurgery (TEM) Collaboration. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg. 2009;96:280–90.

    Article  CAS  Google Scholar 

  15. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45:200–6.

    Article  Google Scholar 

  16. Atallah S, Albert M, Debeche-Adams T, Larach S. Transanal minimally invasive surgery (TAMIS): applications beyond local excision. Tech Coloproctology. 2013;17:239–43.

    Article  CAS  Google Scholar 

  17. Tobias-Machado M, Mattos PAL, Reis LO, Juliano CAB, Pompeo ACL. Transanal minimally invasive surgery (TAMIS) to treat Vesicorectal fistula: a new approach. Int Braz J Urol. 2015;41:1020–6.

    Article  Google Scholar 

  18. Dapri G, Guta D, Cardinali L, Mazzetti C, Febres AC, Grozdev K, Sondji S-H, Surdeanu I, Cadière G-B. A new reusable platform for TransAnal minimally invasive surgery: first experience. Surg Technol Int. 2016;28:85–95.

    PubMed  Google Scholar 

  19. Bislenghi G, Wolthuis AM, de Buck van Overstraeten A, D’Hoore A. AirSeal system insufflator to maintain a stable pneumorectum during TAMIS. Tech Coloproctology. 2015;19:43–5.

    Article  CAS  Google Scholar 

  20. Lee L, Burke JP, deBeche-Adams T, Nassif G, Martin-Perez B, Monson JRT, Albert MR, Atallah SB. Transanal minimally invasive surgery for local excision of benign and malignant rectal neoplasia: outcomes from 200 consecutive cases with midterm follow up. Ann Surg. 2017; https://doi.org/10.1097/SLA.0000000000002190.

  21. Sasaki T, Ito Y, Ohue M, Kanemitsu Y, Kobatake T, Ito M, Moriya Y, Saito N. Postoperative chemoradiotherapy after local resection for high-risk T1 to T2 low rectal cancer: results of a single-arm, multi-institutional, phase II clinical trial. Dis Colon Rectum. 2017;60:914–21.

    Article  Google Scholar 

  22. Ikematsu H, Yoda Y, Matsuda T, et al. Long-term outcomes after resection for submucosal invasive colorectal cancers. Gastroenterology. 2013;144:551–9.

    Article  Google Scholar 

  23. Lee L, Kelly J, Nassif GJ, Atallah SB, Albert MR, Shridhar R, Monson JRT. Chemoradiation and local excision for T2N0 rectal cancer offers equivalent overall survival compared to standard resection: a national cancer database analysis. J Gastrointest Surg. 2017; https://doi.org/10.1007/s11605-017-3536-5.

  24. Rullier E, Rouanet P, Tuech J-J, et al. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet Lond Engl. 2017;390:469–79.

    Article  Google Scholar 

  25. Garcia-Aguilar J, Renfro LA, Chow OS, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16:1537–46.

    Article  Google Scholar 

  26. Kidane B, Chadi SA, Kanters S, Colquhoun PH, Ott MC. Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum. 2015;58:122–40.

    Article  Google Scholar 

  27. Read TEMD, Andujar JEMD, Caushaj PFMD, Johnston DRBA, Dietz DWMD, Myerson RJMD, Fleshman JWMD, Birnbaum EHMD, Mutch MGMD, Kodner IJMD. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum. 2004;47:825–31.

    Article  Google Scholar 

  28. Yeo sG, Kim DY, th K, et al. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KRoG 09- 01). Ann Surg. 2010;252:998–1004.

    Article  Google Scholar 

  29. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Pol- ish Colorectal study Group, et al. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol. 2005;76:234–40.

    Article  Google Scholar 

  30. Bedrosian I, Rodriguez-Bigas MA, Feig B, et al. Predicting the node-negative mesorectum after preoperative chemoradia- tion for locally advanced rectal carcinoma. J Gastrointest Surg. 2004;8:56–62.

    Article  Google Scholar 

  31. Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Scanavini Neto A, Gama-Rodrigues J. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum. 2011;54:545–51.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Colon and Rectal Surgery, Surgery Department, Boston University Medical Center, Boston, MA, USA

    Uma R. Phatak

  2. Division of Colon and Rectal Surgery, Department of Surgery, University of Massachusetts Medical School, University of Massachusetts Memorial Medical Center, Worcester, MA, USA

    Justin A. Maykel

Authors
  1. Uma R. Phatak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Justin A. Maykel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uma R. Phatak .

Editor information

Editors and Affiliations

  1. AdventHealth Orlando, Oviedo Medical Center, and University of Central Florida College of Medicine, Orlando, FL, USA

    Sam Atallah

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Phatak, U.R., Maykel, J.A. (2019). TAMIS: Indications and Contraindications. In: Atallah, S. (eds) Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME). Springer, Cham. https://doi.org/10.1007/978-3-030-11572-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11572-2_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11571-5

  • Online ISBN: 978-3-030-11572-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation